And we could also find the similar tendency in the analysis of HR-Her2-breast cancer (Figures 10C,F), however, the correlation between risk score and tumor immune microenvironment was not statistically significant due to the small number of patients with HR-Her2+ breast cancer (n = 36). This evidence concerns the gene ERBB2 and neoplasm.